Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section

Home Videos Research Press Release Q&A Discussion

almost 12 years ago

The acquiring company may also pay a premium for control. The premium depends on many factors. If the acquiring company's marketing prowess is more important than the value of the drug, there may be little or no premium. However if the drug is more important, then there could be a premium for acquisition.